Even after completing therapy, breast cancer survivors often face a heightened risk of gum inflammation and periodontal diseases. This increased susceptibility arises from medications that can alter ...
Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more ...
The deadline for responses is midnight on 3 November 2025. Gastrointestinal lesions are growths on the lining of the gastrointestinal tract that can be cancerous or develop into cancers. Colorectal ...
Endoscopic submucosal dissection (ESD) enables en bloc resection for early gastrointestinal malignancies but is technically ...
Scientists have demonstrated for the first time how Staphylococcus aureus—a leading cause of skin infections—reshapes the ...
Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscop ...
16d
Tonix Pharmaceuticals Presented Data on TNX-801 Mpox Vaccine at World Vaccine Congress–Europe 2025
TNX-801 is a live virus vaccine investigational candidate, designed to provide durable protection against mpox and smallpoxTNX-801 demonstrated ...
From the stomach to the colon, researchers are uncovering how shifts in the gut microbiome may drive cancers across the ...
Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscop ...
BEVs carry diverse molecular cargo that offers non-invasive biomarkers for early diagnosis and monitoring of PCOS and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback